Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.
Treats serious bacterial infections caused by susceptible isolates of the designated…. Sold as Nebcin, Tobramycin Sulfate. Every FDA application for this active ingredient: 3 branded and 33 generic.
As of Nov 16, 2026, FDA lists 36 applications for Tobramycin Sulfate (sold as Nebcin, Tobramycin Sulfate), first approved Jun 11, 1975, with 3 new uses approved and 0 published complete response letters.
First approved: Jun 11, 1975
Applications: 36
New uses approved: 3
Complete response letters: 0
Medicare spending, 2025: $7.0M
First approved in the EU: Jul 20, 2011
Medicare Spending
CMS Part D and Part B, 2025, before manufacturer rebates; matched by generic name
Tobramycin Sulfate
Part D
$6.9M
-6%
4,976
Tobramycin Sulfate
Part B
$62K
-9%
6,112
What Pharmacies Pay
Median price per unit across package codes in CMS's weekly NADAC survey, Nov 11, 2026, before rebates; see every drug's price change
TOBRAMYCIN 0.3% EYE DROP: $1.10 per MLGeneric · +7% in a year
TOBRAMYCIN 300 MG/5 ML AMPULE: $1.05 per MLGeneric · -21% in a year
TOBRAMYCIN 80 MG/2 ML VIAL: $0.928 per MLGeneric · +14% in a year
Tobi, new approvalA drug with a new route of administration indicated for the improvement of symptoms associated with respiratory infection caused by Pseudomonas aeruginosa… · Novartis Pharma K.K. · Sep 28, 2012
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient.Drugs@FDA